This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.

This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.